Type 2 Diabetes in Pregnancy - Diabetes Clinical Trials

Type 2 Diabetes in Pregnancy

This is an observational, prospective cohort study describing pregnancy outcomes in women with pre-existing (prior to pregnancy) type 2 diabetes who have been exposed to exenatide (BYETTA) during pregnancy.

The primary study objective is to evaluate the percentage of major birth defects (i.e., those that caused significant functional or cosmetic impairment, required surgery, or were life-limiting) following use of exenatide (BYETTA) during pregnancy for treatment of type 2 diabetes compared to the percentage of major birth defects following use of one or more antidiabetic medications other than exenatide during pregnancy for treatment of type 2 diabetes.

This study is being conducted in the United States (US). Enrollment in the Registry is voluntary.

CenterWatch
100 N. Washington St., Suite 301
Boston, MA 02114
Phone: (617) 948-5100
Fax: (617) 948-5101
http://www.centerwatch.com/feedback.html